BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

5395 related articles for article (PubMed ID: 4800288)

  • 41. A phase II study of tamoxifen combined with cisplatin-interleukin 2 and alpha-interferon in metastatic melanoma.
    Antoine EC; Rixe O; Vuillemin E; Benhammouda A; Borel C; Ghironzi GC; Mularoni E; Franks C; Auclerc G; Soubrane C
    Am J Clin Oncol; 1995 Oct; 18(5):421-4. PubMed ID: 7572760
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antitumor activity of combretastatin-A4 phosphate, a natural product tubulin inhibitor.
    Dorr RT; Dvorakova K; Snead K; Alberts DS; Salmon SE; Pettit GR
    Invest New Drugs; 1996; 14(2):131-7. PubMed ID: 8913833
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Retinoid binding lipoprotein in neoplastic cells.
    Sklan D; Lotan R
    Cancer Lett; 1984 Feb; 22(1):41-7. PubMed ID: 6582999
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Configuration of surfaces of human cancer cells obtained by fine needle aspiration biopsy: a comparative light microscopic and scanning electron microscopic study.
    Domagala W; Koss LG
    Acta Cytol; 1980; 24(5):427-34. PubMed ID: 6254296
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Relation between immunogenicity and differentiation of metastasis in an experimental murine melanoma].
    Heinen E; Beckers J; Desaive C; Lennes G; Simar L
    C R Seances Soc Biol Fil; 1982; 176(2):223-6. PubMed ID: 6212110
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Phase I trial of cisplatin, WR-2721, and the murine monoclonal antibody R24 in patients with metastatic melanoma: clinical and biologic effects.
    Bukowski RM; Murthy SA; Finke J; Caulfield MJ; Tubbs R; Herzog P; Stanley J; Edinger M; Tuason L; McLain D
    J Immunother Emphasis Tumor Immunol; 1994 May; 15(4):273-82. PubMed ID: 8061900
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Differentiation of B16 melanoma cells induced by ginsenoside RH2].
    Xia LJ; Han R
    Yao Xue Xue Bao; 1996; 31(10):742-5. PubMed ID: 9863241
    [TBL] [Abstract][Full Text] [Related]  

  • 48. High doses of thymosin alpha 1 enhance the anti-tumor efficacy of combination chemo-immunotherapy for murine B16 melanoma.
    Pica F; Fraschetti M; Matteucci C; Tuthill C; Rasi G
    Anticancer Res; 1998; 18(5A):3571-8. PubMed ID: 9858941
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Angio-tumoral laminin in murine tumors derived from human melanoma cell lines. Immunohistochemical and ultrastructural observations.
    Lugassy C; Christensen L; Le Charpentier M; Faure E; Escande JP
    J Submicrosc Cytol Pathol; 1998 Apr; 30(2):231-7. PubMed ID: 9648287
    [TBL] [Abstract][Full Text] [Related]  

  • 50. S-100 and NSE as serum markers in melanoma.
    Tofani A; Cioffi RP; Sciuto R; Rea S; Festa A; Di Filippo F; Cavaliere R; Maini CL
    Acta Oncol; 1997; 36(7):761-4. PubMed ID: 9490097
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Sinus histiocytosis mimicking metastatic melanoma in lymph nodes of a patient with a large joint prosthesis: case report and review of the literature.
    Charny CK; Jacobowitz G; Melamed J; Tata M; Harris MN
    J Surg Oncol; 1995 Oct; 60(2):128-30. PubMed ID: 7564379
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of large doses of dialysable leukocyte extract.
    Khan A; Benjamin C; Antonetti A; Hill JM
    Proc Soc Exp Biol Med; 1980 Oct; 165(1):91-5. PubMed ID: 6968440
    [No Abstract]   [Full Text] [Related]  

  • 53. Balloon cell metastatic melanoma: an important differential in the diagnosis of clear cell tumours.
    Mowat A; Reid R; Mackie R
    Histopathology; 1994 May; 24(5):469-72. PubMed ID: 8088719
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Molecular genetics of APUDomas.
    Decker RA
    Semin Surg Oncol; 1993; 9(5):380-6. PubMed ID: 7902606
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Adhesive properties of weakly and highly metastatic melanoma cell lines.
    Urushihara H; Ikawa Y; Tsuruo T
    Gan; 1984 Jun; 75(6):534-9. PubMed ID: 6088347
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Differentiation of human fibroblasts to tissue macrophages by the Snyder-Theilen feline sarcoma virus (ST:FeSV): growth modulation of human tumor cell lines in agar.
    Wesseling B; Kopelovich L
    Anticancer Res; 1997; 17(4A):2599-602. PubMed ID: 9252687
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Inhibition of tumor cell adhesion and metastasis].
    Saiki I
    Gan To Kagaku Ryoho; 1993 Feb; 20(3):363-72. PubMed ID: 8439183
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cerebral metastatic malignant melanoma: CT and MR findings with pathological correlation.
    Dewulf P; Demaerel P; Wilms G; Delanote G; Defloor E; Casselman J; Baert AL
    J Belge Radiol; 1993 Oct; 76(5):318-9. PubMed ID: 8119873
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Localization of human ARF2 and NCK genes and 13 other NotI-linking clones to chromosome 3 by fluorescence in situ hybridization.
    Vorobieva N; Protopopov A; Protopopova M; Kashuba V; Allikmets RL; Modi W; Zabarovsky ER; Klein G; Kisselev L; Graphodatsky A
    Cytogenet Cell Genet; 1995; 68(1-2):91-4. PubMed ID: 7956370
    [TBL] [Abstract][Full Text] [Related]  

  • 60. N-methyl-D-aspartate-induced excessive formation of nitric oxide in CHP100 neuroblastoma cells produces death of BMEL melanoma cells in co-culture.
    Corasaniti MT; Melino G; Tartaglia RL; Finazzi-Agrò A; Nisticò G
    Neuropharmacology; 1994 Sep; 33(9):1071-7. PubMed ID: 7838319
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 270.